Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Letter of Support for the Right Drug Dose Now Act
-
ACMG Response to RFI on NIH Genomic Data Sharing Policy
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing